Decongestion improves cell-mediated immunity in postmastectomy arm lymphoedema: a pilot study.

J Eur Acad Dermatol Venereol 2013 Dec 23;27(12):1579-82. Epub 2012 Jul 23.

Department of Dermatology and Allergology, Szeged University, Szeged, Hungary, and Dermatological Research Group, Hungarian Academy of Sciences, Szeged, Hungary.

Background: Chronic lymphoedematous limbs have an increased propensity for infections and primary or secondary malignant tumours. It has been attributed to suppressed delayed-type hypersensitivity measured in lymphoedemas related to Stewart-Treves syndrome, Kaposi's sarcoma or breast cancer treatment. Cell-mediated immunity is an effective defence mechanism against bacteria, fungi, viruses and tumour cells.

Objective: We aimed to examine whether decongestive lymphoedema therapy could improve cell-mediated immunity in breast cancer treatment-related lymphoedema (BCRL).

Methods: Eight women with unilateral BCRL were included in this study. At baseline, tuberculin skin test (TST) was performed on the volar surfaces of the forearms of the affected and non-affected sides using 0.5, 1 and 5 tuberculin units in the form of three consecutive injections with 3-cm spaces in-between, and arm volumes were measured using the Kuhnke's disc model. Decongestive lymphatic therapy was given to swollen arms in 10 consecutive working days. At the end of intensive decongestion, TST on affected side and bilateral volumetry were repeated.

Results: Baseline test using undiluted (5 units) and fivefold diluted (1 unit) tuberculin solutions has shown significant differences (P < 0.05) between the mean sizes (11.81 ± 2.32 and 7.75 ± 1.92; 7.12 ± 1.12 and 5.12 ± 0.91 respectively) in favour to healthy arms. Post therapeutically, the mean sizes were significantly increased (P < 0.05) in the dilutions of 1 : 1 and 1 : 5 (7.75 ± 1.92 and 10.56 ± 1.23 mm, 5.12 ± 0.91 and 5.93 ± 1.74 mm respectively).

Conclusion: Significant increase in TST sizes suggests that decongestive lymphatic therapy is able to partially restore impaired cellular immune function in BCRL.

Download full-text PDF

Source Listing
December 2013
4 Reads

Publication Analysis

Top Keywords

cell-mediated immunity
breast cancer
512 091
decongestive lymphatic
lymphatic therapy
775 192
solutions differences
bcrl included
included study
unilateral bcrl
disc model
bcrlmethods women
differences 005
women unilateral
tuberculin solutions
study baseline
skin test
test tst
fivefold diluted
diluted unit

Similar Publications

Evidence for altered cell-mediated immunity in postmastectomy lymphoedema.

Br J Dermatol 1997 Dec;137(6):928-33

Department of Dermatology, Churchill Hospital, Oxford, U.K.

Patients with chronic lymphoedema are prone to develop chronic infections and various tumours in the lymphoedematous limb, suggesting that regional immune surveillance is impaired. To test the hypothesis that cutaneous cell-mediated immunity is impaired, 35 women with postmastectomy lymphoedema were investigated using dinitrochlorobenzene to test the afferent and efferent loops of the allergic contact immune response. The results support the role of lymphatics as an important component of the immune response to allergens by the demonstration of impairment of both the afferent and efferent loops of the allergic contact dermatitis reaction, and confirm that there is suppression of immune competence in a lymphoedematous limb. Read More

View Article
December 1997

The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL).

Breast 2013 Oct 12;22(5):703-6. Epub 2013 Jan 12.

Department of Physical Medicine and Rehabilitation, Changhua Christian Hospital, 135 Nanxiao Street, Changhua 500, Taiwan. Electronic address:

BCRL is the most common morbidity in women with breast cancer. We performed a retrospective analysis of 107 BCRL patients to identify the efficacy of CDP and the predictors of lymphedema severity and response to CDP. The patients received 12 sessions of CDP, the duration of lymphedema was 22. Read More

View Article
October 2013

Manual lymphatic drainage for chronic post-mastectomy lymphoedema treatment.

Panminerva Med 1998 Mar;40(1):48-50

Rehabilitation and Physical Therapy Unit S. Chiara Hospital, Pisa University, Italy.

Background: The authors evaluated the chronic post-mastectomy lymphoedematous tissue and the effects of manual lymphatic drainage (Leduc method) with and without compressive bandage.

Methods: The arms were measured before and after physical therapy and the results were expressed as a percentage decrease. Physical therapy was performed first by manual lymphatic drainage only and after by manual lymphatic drainage plus compressive bandage. Read More

View Article
March 1998

Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis.

Acta Oncol 2010 ;49(2):166-73

Department of Health Science, Lund University, S-221 00 Lund, Sweden.

Introduction: Arm lymphoedema is a frequent complication after breast cancer treatment. Early diagnosis and treatment is considered important for successful management of breast cancer related arm lymphoedema (BCRL). The purpose was to identify BCRL incidence, time of onset, progression/regression and associated factors 10 years after breast cancer diagnosis. Read More

View Article
April 2010